Treatment of high risk or recurrent meningiomas with hydroxyurea

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Mark A RosenthalLawrence Cher

Abstract

Recurrent, irresectable meningioma constitutes an uncommon but significant problem. Many systemic therapies have been tested without clear evidence of efficacy. More recently, two reports have suggested that hydroxyurea has activity in this context. This study examined the efficacy and toxicity of hydroxyurea in the treatment of 15 patients with high risk meningioma, residual meningioma post resection and progressive meningioma. Hydroxyurea was well tolerated although two patients ceased therapy because of skin rashes. There were no objective responses. Eleven patients achieved stable disease including eight patients who had documented progression prior to commencing hydroxyurea. These results are consistent with previous reports. In conclusion, hydroxyurea may provide some clinical benefit in patients with progressive meningioma by delaying progression of disease.

References

Mar 1, 1996·International Journal of Radiation Oncology, Biology, Physics·M F MilosevicW J Simpson
May 1, 1996·Journal of Neurosurgery·M C Chamberlain
Sep 1, 1996·Journal of Neuro-oncology·A P Kyritsis

❮ Previous
Next ❯

Citations

Sep 23, 2011·Journal of Neuro-oncology·David A ReardonHenry S Friedman
Apr 27, 2012·Journal of Neuro-oncology·Emil LouDavid A Reardon
Feb 3, 2007·Skull Base : Official Journal of North American Skull Base Society ... [et Al.]·Gabriel J WestonMichael J Gleeson
Dec 3, 2013·Neurosurgical Focus·Alan A MoazzamGabriel Zada
Oct 27, 2007·Neurosurgical Focus·Herbert B Newton
Oct 27, 2007·Neurosurgical Focus·Andrew D NordenPatrick Y Wen
May 2, 2008·Neurosurgical Focus·Felix UmanskySergey Spektor
Mar 1, 2013·CNS Oncology·Wendy J Sherman, Jeff J Raizer
Mar 26, 2016·Neurosurgery Clinics of North America·Michael KarsyRandy L Jensen
Mar 18, 2008·Critical Reviews in Oncology/hematology·Christine MarosiCharles Vecht
Jul 10, 2007·The Journal of Small Animal Practice·L MarconatoI Fileccia
May 6, 2004·Journal of Pediatric Hematology/oncology·Matthew M HeeneyRussell E Ware
May 14, 2004·The Neurologist·Katharine J DrummondPeter McL Black
Aug 8, 2018·Biomedicines·Fares NigimYasin Temel
Dec 21, 2006·Cancer·Brian T RagelWilliam T Couldwell
Apr 15, 2003·Current Neurology and Neuroscience Reports·Anthony L D'Ambrosio, Jeffrey N Bruce
Nov 3, 2006·Expert Review of Neurotherapeutics·Patrick Y Wen, Jan Drappatz
May 4, 2011·Current Treatment Options in Oncology·Zanetta Lamar, Glenn J Lesser
Oct 23, 2012·Expert Review of Neurotherapeutics·W J Sherman, J J Raizer
Jan 25, 2013·Journal of Korean Neurosurgical Society·Min-Su KimOh-Lyong Kim
Apr 3, 2018·Neurosurgical Focus·Saksham GuptaIan F Dunn
Sep 8, 2010·Journal of Neuro-oncology·Patrick Y WenAndrew D Norden
Sep 10, 2017·Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine·Li YanYin Zhou
Apr 25, 2018·Journal of the Egyptian National Cancer Institute·Khalid Abdel KarimAhmed Nabeel
Apr 25, 2003·Cancer Control : Journal of the Moffitt Cancer Center·Brian Ragel, Randy L Jensen
Dec 1, 2011·Journal of Neuro-oncology·Marc C Chamberlain
Jul 5, 2012·Current Opinion in Oncology·Marc C Chamberlain
Feb 15, 2011·Journal of Neuro-oncology·Marc C Chamberlain, Sandra K Johnston
Oct 1, 2011·Expert Review of Neurotherapeutics·Marc C Chamberlain, Jill S Barnholtz-Sloan
Apr 9, 2020·BMJ Case Reports·Oriol MirallasMaria Vieito
May 11, 2019·Current Treatment Options in Oncology·Haroon Ahmad, David Schiff
Jun 3, 2021·Cancers·Tamara IusMassimo Robiony
Oct 12, 2021·Current Opinion in Neurology·Thomas GraillonOlivier Chinot

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.